Go online to PeerView.com/BQF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Neurofibromatosis type 1 (NF-1) is a rare autosomal dominant disorder of the nervous system that is associated with significant morbidity, including cutaneous and plexiform neurofibromas, optic pathway gliomas, skin pigmentati ... Show More
Nov 20
Toby Maher, MD, MSc, PhD - Clearing the Air on Fibrosing ILDs: Pulmonologist Conversations on Timely Diagnosis and Modern Care With Antifibrotic Therapy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p><p></p><p>For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA infor ... Show More
56m 46s
Nov 20
Professor Julian Gillmore / Mathew S. Maurer, MD - Exploring New Paradigms in Transthyretin Cardiac Amyloidosis Care: Experts vs AI
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p><p></p><p>For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/A ... Show More
54m 26s
Nov 13
Jiwon Oh, MD, PhD, FRCPC - Quiet Progression, Loud Impact in MS: Expert Insights on the Role of BTK Inhibitors Beyond Relapse
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.</p><p></p><p>For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA infor ... Show More
34m 39s
Aug 2022
Jason Westin, MD, MS, FACP - Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
Go online to PeerView.com/NMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chimeric antigen receptor T-cell (CAR T) therapy, a validated novel therapeutic strategy in leukemic and lymphoid malignancies, continues to provid ... Show More
1h 30m
Mar 2024
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology ... Show More
24m 12s
Jun 2021
Regenerative Medicine Edition Ep.8: Neuroregenerative Therapies
<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Nathan Staff, M.D. (<a href='https://twitter.com/NathanStaffMD'>@NathanStaffMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitt ... Show More
18m 38s
Mar 2022
Richard S. Finn, MD - Mapping the Optimal Treatment Route in HCC: Identifying Best Practices in an Expanding Therapeutic Landscape
Go online to PeerView.com/VMC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.Are you prepared to implement the latest recommended therapies into your hepatocellular carcinoma (HCC) practice? With several available treatment m ... Show More
1h 35m
May 2022
Bradley J. Monk, MD, FACS, FACOG - When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
Go online to PeerView.com/YWA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you optimizing the care of your patients with ovarian cancer with poly (ADP-ribose) polymerase (PARP) inhibitors and novel therapies such as tu ... Show More
56m 25s